Choose your country or region
Merger of ADx NeuroSciences NV and Fujirebio Europe NV
Following the acquisition of ADx NeuroSciences NV by Fujirebio Europe NV in 2022, the merger will officially take effect on 1 April 2026.
What does this mean for ADx NeuroSciences NV customers?
All operations will be conducted under the name Fujirebio Europe NV.
Our commitment to deliver high-quality products and services remain unchanged. The integration of our teams allows us to better support you with an expanded portfolio and a broader range of expertise.
- You will continue to have access to all familiar services and information via the Fujirebio website.
Where should customers find the relevant product information?
- Our ADxPLORER® assays are now listed here.
- Our neuro-related antibodies are listed here.
For further reading, we recommend our Insight article:
Do also feel free to contact us at fnce@fujirebio.com.
site by D'M&S
